Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jill Leigh"'
Autor:
Michael R. Gold, Johan D. Aasbo, Raul Weiss, Martin C. Burke, Marye J. Gleva, Bradley P. Knight, Marc A. Miller, Claudio D. Schuger, Nathan Carter, Jill Leigh, Amy J. Brisben, Mikhael F. El-Chami
Publikováno v:
Heart rhythm. 19(12)
Early subcutaneous implantable cardioverter-defibrillator (S-ICD) studies included atypical cohorts of patients who were younger with fewer comorbidities. Recent S-ICD studies included patient populations with more comorbidities.The goals of this stu
Autor:
Nikolaos Dagres, Glen P. Martin, Zoher Kapacee, Xavier Jouven, Valentina Kutyifa, Serge Boveda, Juhani Junttila, Christian Sticherling, Katherine C. Wu, Rik Willems, Antti M. Kiviniemi, Frieder Braunschweig, Georg Schmidt, Jiri Jarkovsky, Jens Brock Johansen, Mahmoud Suleiman, Alireza Sepehri Shamloo, Artur Akbarov, Laura Fusini, Stephanie Ng, Christian de Chillou, Francisco Leyva, Dick L. Willems, Kevin Kris Warnakula Olesen, Radosław Lenarczyk, Andrea Manca, Youssef Taleb, Arthur A.M. Wilde, Eloi Marijon, Milos Taborsky, Jens Cosedis Nielsen, Niels Peek, Julie Pester, Markus Zabel, Gerhard Hindricks, Gordon F. Tomaselli, Petra Barthel, Chris P Gale, Nancy R. Cook, Golnoosh Motamedi-Ghahfarokhi, Jonas Faxén, Le Mai Parkes, Peter J. Schwartz, Michael Maeng, Christine M. Albert, Gianluca Pontone, Tim Friede, Enrico Longato, Jacob Tflt-Hansen, Manickavasagar Vinayagamoorthy, Daniel Lee, Jan G.P. Tijssen, Ursula Marschall, Tom E Verstraelen, Christopher A. Miller, Hanno L. Tan, Marcus Eng Hock Ong, Petra J. M. Elders, Jill Leigh, Daniel Sprague, Thomas Olsen
Publikováno v:
medRxiv
IntroductionSudden cardiac death (SCD) is the leading cause of death in patients with myocardial infarction (MI) and can be prevented by the implantable cardioverter defibrillator (ICD). Currently, risk stratification for SCD and decision on ICD impl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2429dc925d9f253cc9eafc74d455cd52
https://doi.org/10.1101/2021.07.12.21260002
https://doi.org/10.1101/2021.07.12.21260002
Autor:
Nathan Carter, Raul Weiss, Jill Leigh, Marye J. Gleva, Mikhael F. El-Chami, Johan D. Aasbo, Bradley P. Knight, Claudio Schuger, Mark P. Miller, Marc A. Miller, Michael R. Gold, Martin C. Burke, Amy Jean Brisben
Publikováno v:
Heart Rhythm. 18:S304-S305
Autor:
Brian Olshansky, Leslie A. Saxon, Byron K. Lee, Kent J. Volosin, Fred Ecklund, Elizabeth Galle, Jill Leigh, Thomas Guarnieri, Anupama Rao, Patrick Yong, Gery Tomassoni, Jonathan S. Steinberg, Michael R. Bristow
Publikováno v:
Journal of Cardiovascular Electrophysiology. 20:764-768
Introduction: There are no randomized controlled trial data that evaluate mortality and hospitalization rates in cardiac resynchronization therapy (CRT) recipients based on left ventricular (LV) lead location. We analyzed the event-driven outcomes of
Autor:
Jill Leigh, Michael R. Bristow, Jalal K. Ghali, Leslie A. Saxon, John P. Boehmer, Elizabeth Galle, Fred Ecklund, Patrick Yong, Peter E. Carson, Teresa DeMarco, Arthur M. Feldman
Publikováno v:
Journal of Cardiac Failure. 13:769-773
Objectives We performed a post hoc analysis to determine the influence of cardiac resynchronization therapy with a defibrillator (CRT-D) or without a defibrillator (CRT-P) on outcomes among diabetic patients with advanced heart failure (HF). Backgrou
Autor:
Rui Song, Jill Leigh, JoAnn Lindenfeld, David L. DeMets, Jalal K. Ghali, Inder S. Anand, Patrick Yong, Brian E. Jaski, Michael R. Bristow, Christopher M. O'Connor, Peter E. Carson, Arthur M. Feldman, Jonathan S. Steinberg, Elizabeth Galle, John P. Boehmer, Michael R. Kosorok
Publikováno v:
Circulation. 119(7)
Background— In the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial, 1520 patients with advanced heart failure were assigned in a 1:2:2 ratio to optimal pharmacological therapy or optimal pharmacological t
Autor:
Frank McGrew, John Boehmer, Alan Bank, Elizabeth Galle, Patrick Yong, Jill Leigh, Michael R Bristow
Publikováno v:
Circulation. 118
Cardiac resynchronization therapy (CRT) is typically delivered in addition to background heart failure medications that include beta blockers (BB). Since CRT devices also provide rate support, it was hypothesized that CRT may influence BB use post-im
Autor:
Teresa De Marco, Byron Lee, JoAnn Lindenfeld, Leslie A Saxon, John Boehmer, Mintu Turakhia, Jill Leigh, Patrick Yong, Colleen Curran, Arthur M Feldman, Michael R Bristow
Publikováno v:
Circulation. 118
Background: Although cardiac resynchronization therapy (CRT) has been shown to slow the progression of heart failure (HF), it has not been well described whether the baseline severity of ventricular remodeling influences clinical outcomes. Methods: T
Autor:
Hobby, Jill Leigh.
Publikováno v:
Adobe Acrobat .pdf file, requires Adobe Acrobat Reader software..
Thesis (Ed. D.)--East Tennessee State University, 2004.
Title from electronic submission form. ETSU ETD database URN: etd-0326104-135413. Includes bibliographical references. Also available via Internet at the UMI web site.
Title from electronic submission form. ETSU ETD database URN: etd-0326104-135413. Includes bibliographical references. Also available via Internet at the UMI web site.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.